Substrate Stiffness Coupling TGF-β1 Modulates Migration and Traction Force of MDA-MB-231 Human Breast Cancer Cells in Vitro
journal contributionposted on 2018-02-27, 00:00 authored by Feng Lin, Haihui Zhang, Jianyong Huang, Chunyang Xiong
Cancer cell migration is the hallmark of tumor metastasis; however, the mechanisms of cancer cell migration have not been fully understood. Considering the fact that biophysical and biochemical properties of the tumor microenvironment are altered during tumor progression, it is instinctive to think about whether the changed microenvironment can regulate cancer cell migration. Herein, we cultured human breast cancer cells (MDA-MB-231) on polyacrylamide gel substrates with different stiffnesses (1, 5, 10, and 20 kPa) with and without transforming growth factor-β1 (TGF-β1, 2 ng/mL) treatment to evaluate the effects of the altered tumor microenvironment on cancer cell migration in addition to the response of traction force generation and cytoskeleton remodeling. The results demonstrated that MDA-MB-231 migration increased with increasing substrate stiffness and was further enhanced with TGF-β1 addition. Traction forces and cytoskeleton remodeling were also found to be enhanced in response to TGF-β1 treatment. Furthermore, inhibiting myosin IIA-mediated contraction by blebbistatin decreased TGF-β1-enhanced traction force but increased TGF-β1-enhanced migration. These results imply that both biophysical (like stiffness) and biochemical (like TGF-β1) factors could orthogonally regulate cancer cell migration.
TGF -β1 Modulates Migrationpolyacrylamide gel substratesTGF -β1 additiongrowth factor -β1Vitro Cancer cell migrationtumor microenvironmentMDA-MB -231 migrationtraction force generationmyosin IIA-mediated contractionbreast cancer cellsTGF -β1 treatmentTGF -β1-enhanced migrationMDA-MB -231 Human Breast Cancer Cellscancer cell migrationTGF -β1-enhanced traction force